1. Home
  2. ABCL vs AVNS Comparison

ABCL vs AVNS Comparison

Compare ABCL & AVNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ABCL
  • AVNS
  • Stock Information
  • Founded
  • ABCL 2012
  • AVNS 2014
  • Country
  • ABCL Canada
  • AVNS United States
  • Employees
  • ABCL N/A
  • AVNS N/A
  • Industry
  • ABCL Biotechnology: Pharmaceutical Preparations
  • AVNS Industrial Specialties
  • Sector
  • ABCL Health Care
  • AVNS Health Care
  • Exchange
  • ABCL Nasdaq
  • AVNS Nasdaq
  • Market Cap
  • ABCL 772.9M
  • AVNS 641.7M
  • IPO Year
  • ABCL 2020
  • AVNS N/A
  • Fundamental
  • Price
  • ABCL $2.03
  • AVNS $12.64
  • Analyst Decision
  • ABCL Buy
  • AVNS Hold
  • Analyst Count
  • ABCL 3
  • AVNS 1
  • Target Price
  • ABCL $7.50
  • AVNS N/A
  • AVG Volume (30 Days)
  • ABCL 4.1M
  • AVNS 515.5K
  • Earning Date
  • ABCL 05-08-2025
  • AVNS 05-06-2025
  • Dividend Yield
  • ABCL N/A
  • AVNS N/A
  • EPS Growth
  • ABCL N/A
  • AVNS N/A
  • EPS
  • ABCL N/A
  • AVNS N/A
  • Revenue
  • ABCL $23,114,000.00
  • AVNS $689,200,000.00
  • Revenue This Year
  • ABCL N/A
  • AVNS N/A
  • Revenue Next Year
  • ABCL $36.62
  • AVNS $3.36
  • P/E Ratio
  • ABCL N/A
  • AVNS N/A
  • Revenue Growth
  • ABCL N/A
  • AVNS 1.34
  • 52 Week Low
  • ABCL $1.89
  • AVNS $11.84
  • 52 Week High
  • ABCL $4.34
  • AVNS $25.36
  • Technical
  • Relative Strength Index (RSI)
  • ABCL 34.87
  • AVNS 46.27
  • Support Level
  • ABCL $1.98
  • AVNS $12.35
  • Resistance Level
  • ABCL $2.64
  • AVNS $13.31
  • Average True Range (ATR)
  • ABCL 0.14
  • AVNS 0.44
  • MACD
  • ABCL -0.06
  • AVNS 0.12
  • Stochastic Oscillator
  • ABCL 7.14
  • AVNS 50.92

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is an antibody discovery and development engine that's specifically designed to address the barriers of conventional discovery, finding the optimal clinical candidate with greater precision and speed, getting to the clinic and patients sooner. With the integrated AbCellera platform, the company's experts search a wide range of diverse antibodies to select the effective and developable leads fast and set partners up for enduring success. The company has extensive experience forging partnerships with emerging biotechs and pharmaceutical companies. AbCellera leverages proprietary hardware, software, and tools along with the latest data science, to operate as strategic partners and help develop optimized solutions faster for any program.

About AVNS Avanos Medical Inc.

Avanos Medical Inc is a United States-based company that develops and sells medical devices and related services globally. Its operating and reportable segment provides medical device products to healthcare providers and patients. The company has now changed two franchises: has combined Chronic Care and Pain Management franchises into a single commercial organization focused on the Digestive Health and Pain Management and Recovery product categories that generate its revenue from its Chronic Care franchise and in North America.

Share on Social Networks: